Cargando…
Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis
Angiogenesis is essential for colorectal cancer (CRC) progression, as demonstrated by the beneficial clinical effects of therapeutics inhibiting VEGF signaling. However, alternative mechanisms of neovascularization can develop, resulting in treatment failure. Previously we demonstrated NF-κB-inducin...
Autores principales: | Maracle, Chrissta X., Jeucken, Kim C.M., Helder, Boy, van Gulik, Thomas M., Steins, Anne, van Laarhoven, Hanneke W.M., Tas, Sander W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033358/ https://www.ncbi.nlm.nih.gov/pubmed/29983872 http://dx.doi.org/10.18632/oncotarget.25442 |
Ejemplares similares
-
NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012) -
NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis
por: Noort, Ae R, et al.
Publicado: (2014) -
Rapid stromal remodeling by short‐term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2020) -
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB
por: Liu, Zixu, et al.
Publicado: (2019) -
Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
por: Steins, Anne, et al.
Publicado: (2017)